Article
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
European journal of cancer (Oxford, England : 1990) - 1 Dec 2009
Stocker Gertraud, Ott Katja, Henningsen Nils, Becker Karen, Hapfelmeier Alexander, Lordick Florian, Hois Stefan, Plaschke Susanne, Höfler Heinz, Keller Gisela
Abstract excerpt
PURPOSE: We evaluated DNA polymorphisms in genes related to DNA repair, cell-cycle control and tumour microenvironment to determine possible associations with response and survival in neoadjuvant-treated gastric cancer patients. PATIENTS AND METHODS: One hundred and seventy eight patients who received platinum/5FU-based chemotherapy were genotyped for 10 polymorphisms in nine genes (ERCC1: Asn118Asn, C > T;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
